HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE
Publication
, Conference
Mangiola, M; Sese, D; Lonze, B; Montgomery, R; Jackson, AM; Runstrom, A; Maldonado, AQ
Published in: HUMAN IMMUNOLOGY
2022
Duke Scholars
Published In
HUMAN IMMUNOLOGY
EISSN
1879-1166
ISSN
0198-8859
Publication Date
2022
Volume
83
Start / End Page
36 / 37
Related Subject Headings
- Immunology
- 3204 Immunology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mangiola, M., Sese, D., Lonze, B., Montgomery, R., Jackson, A. M., Runstrom, A., & Maldonado, A. Q. (2022). HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE. In HUMAN IMMUNOLOGY (Vol. 83, pp. 36–37).
Mangiola, M., D. Sese, B. Lonze, R. Montgomery, A. M. Jackson, A. Runstrom, and A. Q. Maldonado. “HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE.” In HUMAN IMMUNOLOGY, 83:36–37, 2022.
Mangiola M, Sese D, Lonze B, Montgomery R, Jackson AM, Runstrom A, et al. HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE. In: HUMAN IMMUNOLOGY. 2022. p. 36–7.
Mangiola, M., et al. “HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE.” HUMAN IMMUNOLOGY, vol. 83, 2022, pp. 36–37.
Mangiola M, Sese D, Lonze B, Montgomery R, Jackson AM, Runstrom A, Maldonado AQ. HLA ANTIBODY TITER INFORMS ABOUT THE RISK OF REBOUND AFTER ANTIBODY DEPLETION WITH IMLIFIDASE. HUMAN IMMUNOLOGY. 2022. p. 36–37.
Published In
HUMAN IMMUNOLOGY
EISSN
1879-1166
ISSN
0198-8859
Publication Date
2022
Volume
83
Start / End Page
36 / 37
Related Subject Headings
- Immunology
- 3204 Immunology
- 1107 Immunology